Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy

被引:8
|
作者
Yang, Xiaolin [1 ]
Zhang, Xiaoqing [1 ]
Shen, Kaifeng [1 ]
Wang, Zhongke [2 ]
Liu, Guolong [1 ]
Huang, Kaixuan [1 ]
He, Zeng [1 ]
Li, Yang [1 ]
Hou, Zhi [1 ]
Lv, Shengqing [1 ]
Zhang, Chunqing [1 ,3 ]
Yang, Hui [1 ,3 ]
Liu, Shiyong [1 ,3 ]
Ke, Yanyan [1 ]
机构
[1] Army Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing, Peoples R China
[2] Armed Police Hosp, Dept Neurosurg, Chongqing, Peoples R China
[3] Chongqing Inst Brain & Intelligence, Guangyang Bay Lab, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
cuproptosis; Fdx1; LIPT1; temporal lobe epilepsy; diagnostic indicator; immune microenvironment; HIPPOCAMPAL SCLEROSIS; CELL-DEATH; COPPER; MICE; DEFICIENCY; METABOLISM; INDUCE;
D O I
10.3389/fphar.2023.1033859
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Temporal lobe epilepsy (TLE) is the most common subtype of epilepsy in adults and is characterized by neuronal loss, gliosis, and sprouting mossy fibers in the hippocampus. But the mechanism underlying neuronal loss has not been fully elucidated. A new programmed cell death, cuproptosis, has recently been discovered; however, its role in TLE is not clear.Methods: We first investigated the copper ion concentration in the hippocampus tissue. Then, using the Sample dataset and E-MTAB-3123 dataset, we analyzed the features of 12 cuproptosis-related genes in TLEs and controls using the bioinformatics tools. Then, the expression of the key cuproptosis genes were confirmed using real-time PCR and immunohistochemical staining (IHC). Finally, the Enrichr database was used to screen the small molecules and drugs targeting key cuproptosis genes in TLE.Results: The Sample dataset displayed four differentially expressed cuproptosis-related genes (DECRGs; LIPT1, GLS, PDHA1, and CDKN2A) while the E-MTAB-3123 dataset revealed seven DECRGs (LIPT1, DLD, FDX1, GLS, PDHB, PDHA1, and DLAT). Remarkably, only LIPT1 was uniformly upregulated in both datasets. Additionally, these DECRGs are implicated in the TCA cycle and pyruvate metabolism-both crucial for cell cuproptosis-as well as various immune cell infiltrations, especially macrophages and T cells, in the TLE hippocampus. Interestingly, DECRGs were linked to most infiltrating immune cells during TLE's acute phase, but this association considerably weakened in the latent phase. In the chronic phase, DECRGs were connected with several T-cell subclasses. Moreover, LIPT1, FDX1, DLD, and PDHB were related to TLE identification. PCR and IHC further confirmed LIPT1 and FDX1's upregulation in TLE compared to controls. Finally, using the Enrichr database, we found that chlorzoxazone and piperlongumine inhibited cell cuproptosis by targeting LIPT1, FDX1, DLD, and PDHB.Conclusion: Our findings suggest that cuproptosis is directly related to TLE. The signature of cuproptosis-related genes presents new clues for exploring the roles of neuronal death in TLE. Furthermore, LIPT1 and FDX1 appear as potential targets of neuronal cuproptosis for controlling TLE's seizures and progression.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Validation of a Novel Cuproptosis-Related Prognostic Gene Marker and Differential Expression Associated with Lung Adenocarcinoma
    Liu, Tingting
    Wei, Jianshe
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (10) : 8502 - 8518
  • [32] Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
    Xu, Miaorong
    Mu, Jiayi
    Wang, Jiaojiao
    Zhou, Qin
    Wang, Jianwei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma
    Yang, Weiguang
    Wu, Haiyang
    Tong, Linjian
    Wang, Yulin
    Guo, Qiang
    Xu, Lixia
    Yan, Hua
    Yin, Chengliang
    Sun, Zhiming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Identification and validation of cuproptosis-related genes for diagnosis and therapy in nonalcoholic fatty liver disease
    Li, Jinquan
    Zhang, Yi
    Ma, Xiaohan
    Liu, Ruiqi
    Xu, Cuicui
    He, Qin
    Dong, Ming
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025, 480 (01) : 473 - 489
  • [35] Exploration of a Predictive Model for Keloid and Potential Therapeutic Drugs Based on Immune Infiltration and Cuproptosis-Related Genes
    Liu, Jiaming
    Hu, Ding
    Wang, Yaojun
    Zhou, Xiaoqian
    Jiang, Liyuan
    Wang, Peng
    Lai, Haijing
    Wang, Yu
    Xiao, Houan
    JOURNAL OF BURN CARE & RESEARCH, 2024, 45 (05) : 1217 - 1231
  • [36] Bioinformatics reveals diagnostic potential of cuproptosis-related genes in the pathogenesis of sepsis
    Sun, Zhongyi
    Zhao, Qiuyue
    Zhang, Jiahao
    Hu, Yanan
    Qu, Jiachen
    Gao, Han
    Peng, Zhiyong
    HELIYON, 2024, 10 (01)
  • [37] Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
    Tan, Wei
    Dai, Fangfang
    Ci, Qinyu
    Deng, Zhimin
    Liu, Hua
    Cheng, Yanxiang
    BMC WOMENS HEALTH, 2025, 25 (01)
  • [38] Clinical significance and potential application of cuproptosis-related genes in gastric cancer
    Yan, Jia-Ning
    Guo, Li-Hua
    Zhu, Dan-Ping
    Ye, Guo-Liang
    Shao, Yong-Fu
    Zhou, Han-Xuan
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (07) : 1200 - 1214
  • [39] Commentary: Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
    Du, Yi-Heng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Identification of DLAT as a potential therapeutic target via a novel cuproptosis-related gene signature for the prediction of liver cancer prognosis
    Xia, Cunbing
    Chen, Yang
    Zhu, Yongkang
    Chen, Dexuan
    Sun, Haijian
    Shen, Tong
    Shelat, Vishal G.
    Mavroeidis, Vasileios K.
    Sandri, Giovanni Battista Levi
    Wang, Zhan
    Zhu, Hong
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (05)